Stay updated on BEAT-MS Clinical Trial
Sign up to get notified when there's something new on the BEAT-MS Clinical Trial page.

Latest updates to the BEAT-MS Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov site revision label updates from v3.8.0 to v3.8.1, while the study details remain unchanged.SummaryDifference0.0%

- Check9 days agoChange DetectedThe BEAT-MS study record is now displayed, describing a Phase 3 comparison of autologous stem cell transplantation and best available therapy for treatment-resistant relapsing multiple sclerosis. It also provides participant eligibility and location details, study outcomes, and information about sharing study data.SummaryDifference100%

- Check16 days agoChange DetectedThe site revision displayed in the footer changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check30 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check44 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1. The page continues to show a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now displays a 403 Forbidden message instead of the study record content, indicating that access to the BEAT-MS study details is blocked.SummaryDifference23%

Stay in the know with updates to BEAT-MS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BEAT-MS Clinical Trial page.